Current Month 2013
Article Features
  Antibody Slows Tumor Growth and Metastasis in Mice
Breast Cancer Patients and Post-Traumatic Stress Disorder
Cancer Cells Show Resilient Nuclear Rupture Repair, But Expose Weakness in Doing So
Cancer-Causing Gene Triggered by Alcohol May Increase Breast Cancer Risk
“Dose Dense” Chemo for Premenopausal Breast Cancer Patients Improves Survival
How A Pill Could Improve Breast Cancer Diagnoses
How Cancer Stem Cells Thrive When Oxygen is Scarce
Lapatinib and Trastuzumab Shrinks HER2+ Breast Cancer in 11 Days After Diagnosis
Male Breast Cancer Patients Disadvantaged By Lack of Research
Mammograms: Another Way to Screen for Heart Disease?
Multi-Gene Test Identifies Early Breast Cancer Patients Who Can Be Spared Chemo
New Breast Cancer Staging System Emphasizes Importance of Tumor Biology as Prognostic Indicator
New Gene Identified as Cause, Early Indicator of Breast Cancer
New, Less Toxic Therapy for Stage-4 Breast Cancer
NIST Develops First Useful Measurement Standard for Breast Cancer MRI
Pathologists Often Disagree on Breast Biopsy Results When Diagnosing DCIS
Processed Meat May Increase the Risk of Breast Cancer For Latinas, Study Finds
Prolonged Nightly Fasting May Reduce Risk of Breast Cancer Recurrence
Quality of Life Not Notably Better for Women Choosing Double Mastectomy
Racial, Socioeconomic Disparities in Genomic Test Used in Early-Stage Breast Cancer
Rates of Prophylactic Mastectomy Have Tripled in Past Decade Despite No Survival Benefit
Screening with Tomosynthesis or Ultrasound Detects More Cancers in Dense Breasts

Pathologists Often Disagree on Breast Biopsy Results When Diagnosing DCIS

A study applying B-Path (Breast Pathology) Study results to patient populations found that pathologists disagree with one another about 8 percent of the time when diagnosing a single breast biopsy slide. Discordance was more likely in cases of DCIS or atypia, with a tendency toward overdiagnosing disease. The findings are published in the journal Annals of Internal Medicine.

Results of the B-Path Study, an evaluation of diagnostic agreement among pathologists interpreting breast biopsy specimens, raised concerns about the accuracy of breast cancer diagnoses in general clinical practice. However, the study was not intended to reflect population impact. To provide a more clinically relevant assessment of accuracy than previously reported, researchers analyzed the B-Path Study data using U.S. population-adjusted estimates. The researchers estimated the probability that a pathologist's interpretation of a single breast biopsy slide would be confirmed by a consensus-based reference standard derived from three expert breast pathologists interpreting the same slide. For example, if a single slide from a woman's biopsy was interpreted as DCIS, how likely is it that her slide would get the same diagnosis from a panel of three expert pathologists?

The researchers found that pathologists were likely to agree on invasive breast cancer diagnoses, but agreement was substantially lower for interpretations of DCIS and atypia. For example, 1 in 5 women with an initial diagnosis of DCIS would have her biopsy specimen interpreted as atypia or benign by the reference consensus panel and half of the women with atypia would have their diagnosis downgraded to benign without atypia.

Read More of the Main Article

Visit the Ezine

Visit the BreastCenter

Visit the Quality Corner
Avon Breast Cancer Crusade - AVON the company for women

  This website is supported in part by an unrestricted educational grant provided by Avon